Loading...
7 Immunodeficiencies Reports
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Pharmacosmos, AMAG Pharmaceuticals, Sanofi, Abbvie, Fresenius
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Merck, Cipla, Bristol-Myers Squibb, Viatris, Johnson & Johnson
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Sanofi, Abbvie, Pharmacosmos, Covis Pharma, Pfizer
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Astellas Pharma, Bristol-Myers Squibb, Novartis, Sanofi, Roche
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Baxter, Takeda Pharmaceuticals, CSL Behring, Octapharma, Biotest
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Marinus Pharmaceuticals, Zogenix, REGENXBIO, Longboard Pharmaceuticals, Ovid Therapeutics
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America, Global
Major Players: Novartis, Gilead Sciences, Dendreon Pharmaceuticals, JW CreaGene, GC Biopharma
Filter Reports
By Region
By Countries
